Asia-Pac J Clncl Oncology - 2024 - Bacorro - The Case for Shared Decision‐making in Oncology and Why the Philippine (1)
Asia-Pac J Clncl Oncology - 2024 - Bacorro - The Case for Shared Decision‐making in Oncology and Why the Philippine (1)
Asia-Pac J Clncl Oncology - 2024 - Bacorro - The Case for Shared Decision‐making in Oncology and Why the Philippine (1)
EDITORIAL
1
The Graduate School, University of Santo Tomas, Manila, Philippines 2 Department of Clinical Epidemiology, Faculty of Medicine and Surgery, University of
Santo Tomas, Manila, Philippines 3 Department of Radiation Oncology, University of Santo Tomas Hospital – Benavides Cancer Institute, Manila, Philippines
4
Gynecologic Oncology Unit, University of Santo Tomas Hospital – Benavides Cancer Institute, Manila, Philippines 5 Management Office, Philippine Cancer
Center, Quezon City, Philippines 6 Department of Obstetrics and Gynecology, Manila Doctors Hospital, Manila, Philippines 7 Department of Nursing
Services, University of Santo Tomas Hospital, Manila, Philippines 8 Department of Obstetrics and Gynecology, Faculty of Medicine and Surgery, University of
Santo Tomas, Manila, Philippines 9 Department of Obstetrics and Gynecology, University of Santo Tomas Hospital, Manila, Philippines 10 Department of
Psychology, College of Science, University of Santo Tomas, Manila, Philippines
Funding: This work was partly subsidized by the Philippine Council for Health and Research Development which has no role in the development and design of
any aspect of the prototype development and evaluation or influence over any decision relating to the conduct of the study and writing and publication of the
study report.
1 The Case for Shared Decision-Making unrecognized coercion. However, shared decision-making goes
beyond informed consent.
Shared decision-making is a collaborative approach to care
planning where the patient and their clinicians work together The case for shared decision-making is a matter of cost-
to address a dilemma in the patient’s care through an equal effectiveness. In oncology, where treatment has evolved to
conversation [1, 2]. This entails an evaluation of the situation by become highly specialized, multidisciplinary, and personalized,
considering both the insights of the interdisciplinary healthcare clinical practice guidelines and clinical evaluation tools have been
team regarding the patient’s disease, overall health status, and developed to facilitate evidence-based decision-making. How-
available treatment options, and the perspectives of the patient ever, while much has been put into “personalizing” treatment in
and their family regarding values, preferences, and resources [3, terms of the patient’s medical profile and disease characteristics,
4]. less has been put into personalizing in terms of the person’s
values and preferences. The costliest treatment is one that does
The case for shared decision-making is ethical. The principles not work; an even costlier treatment is one that the patient does
of autonomy and informed consent underlie all healthcare. One not want or one that the patient did not know they did not
may argue that not all patients prefer to make the decision want—the cost is decisional regret. Aligning treatment choices to
or actively take part in the decision-making. Some patients patient values and preferences and managing patient and family
may want to be involved in the decision-making but may not expectations of the treatment are both paramount. However,
feel capable of making the decision; a next of kin, a legal shared decision-making is more than patient-centeredness.
representative, or a patient navigator or coach may help enable
the patient. Some patients may entirely defer to the physician’s The case for shared decision-making is a matter of efficiency.
recommendation but the setting for shared decision-making Fragmented care is inefficient care delivery. The multidisci-
should be in place and offered to avoid any unintended or plinary tumor board is a recognized standard of care; not only
Clinicians may not feel that shared decision-making is suitable Shared decision-making goes together with contextualized
for all patients due to decisional preferences [8]. In a survey evidence-based medicine. The Department of Health of
among Filipino patients with advanced cancers, up to 22% the Philippines has successfully developed national clinical
reported a preference for passive decisional control [12]. Patient practice guidelines for several cancers that also serve to guide
decision aids may enhance patient autonomy and engagement in health financing [21], a testament that the Philippine medical
the decision-making and implementation. Patient decision aids, community already has trained experts in evidence-based
by incorporating patient-level information summaries, values oncology. However, while patient survivors and advocates were
weighing scales, and guidance on decision-making, serve to engaged in the development of these guidelines, guidance on
supplement clinic discussions as they can be accessed by patients the practical implementation of shared decision-making in these
and their families outside consultation times at their own pace guidelines is lacking.
3 of 4
17437563, 0, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/ajco.14143 by Warren Bacorro - University Of Santo Tomas , Wiley Online Library on [30/11/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
Cisplatin-Intolerant Patients with Locally Advanced Cervical Cancer
(CECIL). 2024.
18. Ready Steady Go, Transition & Patient Empowerment Innovation,
Education and Research Collaboration [Internet]. 2022. Available from:
https://www.readysteadygo.net/
19. NHS England, Shared Decision Making: Summary Guide [Internet].
2019. Available from: https://www.england.nhs.uk/publication/shared-
decision-making-summary-guide/
20. A. S. Carvalho, D. Ivanković, E. Barbazza, O. B. Fernandes,
N. Klazinga, and D. Kringos, Action Guide For Efficient Cancer
Care: An Implementation Toolkit [Internet]. 2024. Available from:
https://www.all-can.org/what-we-do/policy-research/action-guide-for-
efficient-cancer-care/
21. Department of Health (Philippines), Compendium of DOH-Approved
Clinical Practice Guidelines [Internet]. 2023. Available from: https://doh.
gov.ph/dpcb/doh-approved-cpg
22. W. Bacorro, K. Baldivia, J. Mariano, et al. “Patient Decision Aid for
Chemotherapy or Exclusion in Cisplatin-Intolerant Patients with Locally
Advanced Cervical Cancer (CECIL): Development, Alpha Testing and
Peer Validation,” JCO Global Oncology 9, (2023): e2300096. https://doi.
org/10.1200/GO.23.00096.
23. W. Bacorro, K. Baldivia, J. Mariano, et al. “Patient Decision Aid
for Chemotherapy or Exclusion in Cisplatin-Intolerant Patients with
Locally Advanced Cervical Cancer (CECIL): Protocol for Development,
Validation and Clinical Testing,” J Hosp Manage and Health Policy (2023),
https://doi.org/10.1200/GO.23.0009610.21037/jhmhp-23-9.
24. Congress of the Philippines, National Integrated Cancer Control
Act [Internet]. 2018. Available from: https://www.officialgazette.gov.ph/
downloads/2019/02feb/20190214-RA-11215-RRD.pdf